Market Size of Global Digital Dose Inhaler Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 13.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Digital Dose Inhaler Market Analysis
The digital dose inhaler market is anticipated to grow with a CAGR of above 13.3% during the forecast period.
COVID-19 pandemic had a significant impact on the global digital dose inhaler market, due to patients with asthma and chronic obstructive pulmonary disease (COPD) being considered at increased risk of hospitalization from COVID-19. According to the article titled "Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study" published in January 2022 adults with asthma were found to be at an increased risk of COVID-19 hospital admission compared with those without asthma conditions. Thus, increasing cases of COVID-19 are rising the cases of respiratory disorders which generates the need for digital dose inhalers. Thus COVID-19 had a significant impact on the growth of the market during the pandemic period.
The major factors attributing to the growth of the digital dose inhaler market include the rising prevalence of chronic respiratory diseases and the growing demand for technology-enabled features of respiratory devices.
Soaring geriatric populations suffering from respiratory disorders and favorable reimbursement policies also play a significant role in the growth of the market. According to the article titled "Common Respiratory Disorders in Seniors" published in April 2020 around 15% of older adults from asthma, chronic obstructive pulmonary disease, or another respiratory disorder. The rising prevalence of respiratory diseases globally is expected to drive the demand for digital dose inhalers, thereby contributing to the growth of the market.
Additionally, the increasing product launches are expected to contribute to the growth of the market. For instance, in December 2021 NuvoAir, launched an add-on sensor for asthma and chronic obstructive pulmonary disease inhalers as a part of its chronic care ecosystem.
Thus, the above-mentioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of the inhalers is a constraint to the growth of the market.
Digital Dose Inhaler Industry Segmentation
As per the scope of the report, digital dose inhalers are devices that deliver a specific amount of medication to the lungs in the form of aerosolized medicine or dry powder. The Digital Dose Inhaler Market is Segmented by Product (Dry Powder Inhalers and Metered Dose Inhalers), Application (Chronic Obstructive Pulmonary Disease, Asthma and Others), Type (Branded and Generic), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | |
| Dry Powder Inhalers | |
| Metered Dose Inhalers |
| By Application | |
| Chronic Obstructive Pulmonary Disease | |
| Asthma | |
| Others |
| By Type | |
| Branded | |
| Generic |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Digital Dose Inhaler Market Size Summary
The digital dose inhaler market is poised for significant growth, driven by the increasing prevalence of chronic respiratory diseases and the demand for technology-enabled respiratory devices. The COVID-19 pandemic has notably impacted the market, as individuals with asthma and chronic obstructive pulmonary disease (COPD) were at a higher risk of severe outcomes, thereby elevating the need for digital dose inhalers. The market is further bolstered by the aging population with respiratory disorders and favorable reimbursement policies. The introduction of innovative products, such as NuvoAir's add-on sensor and Berry Global's RS01 dry powder inhaler, underscores the ongoing advancements in the sector. Despite the high cost of inhalers posing a challenge, the market is expected to expand due to these driving factors.
North America is anticipated to lead the digital dose inhaler market, supported by the rising incidence of respiratory conditions among both children and the elderly. The region benefits from a high prevalence of asthma, particularly among adult women, and a steady stream of product launches, such as Teva Pharmaceuticals' digital inhalers. The market is moderately competitive, with key players like Glenmark Pharmaceuticals, AstraZeneca, and Novartis International AG at the forefront. Collaborations, such as the partnership between AstraZeneca and Honeywell to develop eco-friendly inhalers, and innovations like Aptar Pharma's HeroTracker Sense, highlight the dynamic nature of the market. These factors collectively contribute to the anticipated growth of the digital dose inhaler market over the forecast period.
Global Digital Dose Inhaler Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Chronic Respiratory Diseases
-
1.2.2 Soaring Geriatric Population Afflicted With Respiratory Disorders
-
1.2.3 Increasing R&D Investment for Technological Improvement and Device Miniaturization
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Devices
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Dry Powder Inhalers
-
2.1.2 Metered Dose Inhalers
-
-
2.2 By Application
-
2.2.1 Chronic Obstructive Pulmonary Disease
-
2.2.2 Asthma
-
2.2.3 Others
-
-
2.3 By Type
-
2.3.1 Branded
-
2.3.2 Generic
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Digital Dose Inhaler Market Size FAQs
What is the current Global Digital Dose Inhaler Market size?
The Global Digital Dose Inhaler Market is projected to register a CAGR of 13.30% during the forecast period (2024-2029)
Who are the key players in Global Digital Dose Inhaler Market?
Propeller Health, Koninklijke Philips N.V., Novartis International AG and Teva Pharmaceuticals Inc., are the major companies operating in the Global Digital Dose Inhaler Market.
